BURLINGTON – A new test developed by Labcorp can help people find treatment options for skin cancer. The test, which Labcorp announced in a statement, is available for use in clinical trials and for ...

BURLINGTON, N.C.--(BUSINESS WIRE)--Nearly 10 million people in the United States have a history of systemic or anaphylactic reaction to insect stings, with the risk of a severe and potentially ...

Labcorp added to its suite of tests designed to detect cancer recurrence much earlier than traditional imaging.

Stinging Insect Component Testing Combined with Interpretative Report Offers Enhanced Patient Management “Labcorp is the only reference laboratory to offer stinging insect (venom) component testing,” ...